CytRx Corporation (CYTR)

0.36
0.01 2.86
OTC
Prev Close 0.35
Open 0.33
Day Low/High 0.33 / 0.36
52 Wk Low/High 0.26 / 1.30
Volume 105.45K
Exchange OTC
Shares Outstanding 33.64B
Market Cap 12.61M
Div & Yield N.A. (N.A)
Federman & Sherwood Reminds Investors Of Imminent Lead Plaintiff Deadline In Securities Class Action Lawsuit Against CytRx Corporation

Federman & Sherwood Reminds Investors Of Imminent Lead Plaintiff Deadline In Securities Class Action Lawsuit Against CytRx Corporation

On July 25, 2016, a class action lawsuit was filed in the United States District Court for the Central District of California against CytRx Corporation (NASDAQ: CYTR).

STOCK NOTICE: Rosen Law Firm Reminds CytRx Corporation Investors Of Important Deadline In Class Action

STOCK NOTICE: Rosen Law Firm Reminds CytRx Corporation Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of CytRx Corporation securities (NASDAQ:CYTR) from November 18, 2014 through July 11, 2016, both...

Robbins Arroyo LLP: CytRx Corporation (CYTR) Misled Shareholders According To A Recently Filed Class Action

Robbins Arroyo LLP: CytRx Corporation (CYTR) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against CytRx Corporation (NASDAQCM: CYTR) in the U.

INVESTOR ALERT: Brower Piven Notifies Shareholders Of Securities Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In CytRx Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline

INVESTOR ALERT: Brower Piven Notifies Shareholders Of Securities Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In CytRx Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

CytRx Corporation Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

CytRx Corporation Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

CytRx (CYTR) Strong On High Relative Volume Today

CytRx (CYTR) Strong On High Relative Volume Today

Trade-Ideas LLC identified CytRx (CYTR) as a strong on high relative volume candidate

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

Here's a technical look at how to trade five stocks that are ready to break out and trade higher from current levels.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CytRx Corporation - CYTR

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against CytRx Corporation - CYTR

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of CytRx Corporation securities (NASDAQ: CYTR) from November 18, 2014 through July 11, 2016, both...

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of CytRx Corporation Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray Announces The Filing Of A Securities Class Action On Behalf Of CytRx Corporation Investors And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") announces that it has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of investors who purchased CytRx...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of CytRx Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of CytRx Corporation

Levi & Korsinsky announces it has commenced an investigation of CytRx Corporation (NASDAQ:CYTR) ("CytRx") concerning possible violations of federal securities laws by the Company and/or certain of its officers and...

Interesting CYTR Put And Call Options For March 2017

Interesting CYTR Put And Call Options For March 2017

Investors in CytRx Corp saw new options become available today, for the March 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation Of CytRx Corporation And Reminds Investors With Losses To Contact The Firm

SHAREHOLDER NOTICE: Khang & Khang LLP Announces An Investigation Of CytRx Corporation And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against CytRx Corporation ("CytRx" or the "Company") (Nasdaq: CYTR) concerning possible violations of federal securities laws.

Trade-Ideas: CytRx (CYTR) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: CytRx (CYTR) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified CytRx (CYTR) as a weak on high relative volume candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of CytRx Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of CytRx Corporation

Levi & Korsinsky announces it has commenced an investigation of CytRx Corporation (NASDAQ: CYTR) ("CytRx") concerning possible violations of federal securities laws by the Company and/or certain of its officers and...

CytRx Sarcoma Drug Flops in Late-Stage Clinical Trial

CytRx Sarcoma Drug Flops in Late-Stage Clinical Trial

The aldoxorubicin sarcoma study failure leaves CytRx with a depleted pipeline and 40 cents per share in cash.

Biotech Stock Mailbag: Why Intrexon CEO R.J. Kirk Should Not Be Trusted

Biotech Stock Mailbag: Why Intrexon CEO R.J. Kirk Should Not Be Trusted

TheStreet's Adam Feuerstein answers reader questions about biotech stocks.

CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail

CytRx Bear Thesis Explained: Why Sarcoma Drug Trial Will Fail

Data from CytRx's phase III study of aldoxorubicin for the treatment of patients with soft-tissue sarcoma are being analyzed right now, with results expected toward the end of June.

CytRx (CYTR) Flagged As Strong On High Volume

CytRx (CYTR) Flagged As Strong On High Volume

Trade-Ideas LLC identified CytRx (CYTR) as a strong on high relative volume candidate

CYTR December 16th Options Begin Trading

CYTR December 16th Options Begin Trading

Investors in CytRx Corp saw new options begin trading today, for the December 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CytRx (CYTR) Strong On High Relative Volume Today

CytRx (CYTR) Strong On High Relative Volume Today

Trade-Ideas LLC identified CytRx (CYTR) as a strong on high relative volume candidate

CytRx (CYTR) Stock: Weak On High Volume Today

CytRx (CYTR) Stock: Weak On High Volume Today

Trade-Ideas LLC identified CytRx (CYTR) as a weak on high relative volume candidate

First Week of May 20th Options Trading For CytRx (CYTR)

First Week of May 20th Options Trading For CytRx (CYTR)

Investors in CytRx Corp saw new options become available this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYTR options chain for the new May 20th contracts and identified one put and one call contract of particular interest.

Interesting CYTR Put And Call Options For April 15th

Interesting CYTR Put And Call Options For April 15th

Investors in CytRx Corp saw new options begin trading this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYTR options chain for the new April 15th contracts and identified one put and one call contract of particular interest.

First Week of September 16th Options Trading For CytRx (CYTR)

First Week of September 16th Options Trading For CytRx (CYTR)

Investors in CytRx Corp saw new options become available this week, for the September 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 217 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of June 2016 Options Trading For CytRx (CYTR)

First Week of June 2016 Options Trading For CytRx (CYTR)

Investors in CytRx Corp saw new options become available this week, for the June 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Short Interest In CytRx Decreases By 10.4%

Short Interest In CytRx Decreases By 10.4%

The most recent short interest data has been released by the NASDAQ for the 07/31/2015 settlement date, which shows a 1,135,317 share decrease in total short interest for CytRx Corp , to 9,789,941, a decrease of 10.39% since 07/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Fly Watch: Several Names That May Move Following ASCO Meeting

Fly Watch: Several Names That May Move Following ASCO Meeting

The American Society of Clinical Oncology, or ASCO, is holding the society's 51st annual meeting from May 29 to June 2 in Chicago, Illinois.

First Week of July 17th Options Trading For CytRx (CYTR)

First Week of July 17th Options Trading For CytRx (CYTR)

Investors in CytRx Corp saw new options begin trading this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CYTR options chain for the new July 17th contracts and identified one put and one call contract of particular interest.

CytRx (CYTR) Is Weak On High Volume Today

CytRx (CYTR) Is Weak On High Volume Today

Trade-Ideas LLC identified CytRx (CYTR) as a weak on high relative volume candidate

TheStreet Quant Rating: D- (Sell)